$ CMPS! once in a decade opportunity with a product that will change the whole field of psychiatry or better yet hopefully change the world.

**Disclaimer**: I work professionally in mental health field and involved in clinical care and research. I am a casual trader, so this is not a financial advise, I will let the professionals in the comment section to refine this DD further. Will post this in few subs, it’s not pump and dump, It isPUMP, PUMP, PUMP-> MOON **TLDR**: magic shrooms 🍄🍄 showed amazing phase 3 data which can treat millions of patient around the world Suffering with depression. This company has potential to grow ten folds in upcoming years. Ask any doubts regarding the clinical side of things which can make a case for bearish scenarios and I will respond. Here we go!! Depression is the biggest and leading cause of disability and years of quality life lost around the world. Unlike other aspects of medicine, we have not made much progress in treating depression. Our best options are antidepressants like SSRI’s which do not even work in half the patients, and is similar to putting bandage on a gunshot wound. We also got ketamine recently (courtesy of johnson and Johnson) which recently got approved, will give you relief for few days and then depression is back again until you keep shelling money into those expensive ketamine parlours. Despite that, J and J is making billions of dollars from ketamine in the US alone. 330 million people suffer from depression and rates are rising at a high rate and the currently approved treatments are not making a dent. I am sure everybody knows someone who has or is battling depression. This new drug Comp 360 ( actually very old in nature, fancy name of chemical found in magic mushrooms 🍄) has shown statistical and clinically significant improvement in the most severe patients with depression (TRD) who have already failed 2 or more gold standard antidepressants( Imagine what it can do in much milder patients) Enough science, lets talk $$$$ now!!! Here is my hand written sloppy full of grammatical mistakes DD( reddit is not allowing me to copy paste from chat gpt) In 2021, psychedelic companies like DFTI, ATAI, HELP launched their IPO’s and the stocks went to 50-120$. soon, the hype died down as this trials take years and go through very rigorous regulations, all stock prices fell in sub 5 dollar range making them borderline penny stocks( I am not a bag holder). They stayed there for a while and the clinical trials progressed from phase 1 to phase 2. Compass pathway (CMPS)and (DFTI) products got FDA breakthrough designation because of their phase 2 trial results. Breakthrough designation means that this therapy has performed overwhelmingly better in phase 2 compared to current gold standard treatment and have the potential to become best available therapy, and they usually fast track these trials so they get approved as fast as possible. This is a big thing. That is when their stock prices started picking up. But phase 3 trials take few years, so they still did not get the attention they deserved, CMPS stock increased by 100 percent but started dipping again due to long wait. Past year, it increased by 60-70 percent and today the news of phase 3 success came out and stock prices started picking jumped upto 50 percent in a single day. It is currently at $7.34. And will likely keep on increasing slowly. Some analyst (i know they dont mean jackshit) have predicted 12 month target in high 20’s to mid 30’s by the end of the year. What’s next: Company will file for FDA approval, and historically breakthrough therapies have more than 70 percent chances of approval, even before positive phase 3 data. So chances of this being approved is more than 70 percent. Once it gets approved and they commercialise the product, It can capture market for millions of people and has potential of earning billions of dollar every year. Since this is a first commercial success for a classic psychedelic drug( ketamine and MDMA are not psychedelics) there is a high chance of it being bought by big pharma for billions of dollars. I mean who wouldn’t wanna try magic mushrooms, especially if their life is very very sad. the people in the field are all talking about it but I do not think, people outside psychiatry have much idea about them Being this close to being approve. This stock has the potential to 10X in a few years, or 10 X this year, If big pharma buys the company. Let me know if you have any doubts or thoughts in the comment. I will also comment the AI slop with shiny numbers for people who love that kind of thing. TLDR: magic shrooms 🍄🍄showed amazing phase 3 data which can treat millions of patient around the world Suffering with depression. This company has potential to grow ten folds in upcoming years. Ask any doubts regarding the clinical side of things which can make a case for bearish scenarios and I will respond. Here we go!!